Oncology Therapeutics / NCI
Verified Pharmaceutical Manufacturer & Oncology Drug Supplier
Oncology Therapeutics / NCI
Verified PartnerRegistered pharmaceutical manufacturer and healthcare technology supplier listed on the ONC-ORG national directory.
Company Profile & Registration
Legal Organization NameOncology Therapeutics / NCI
Manufacturer Identification CodeRegistered
Authorized RepresentativeCorporate Representative
Compliance & StatusActive / Listed
Oncology Drugs & Clinical Formulations
Featured Drug Formulation
View Complete Drug Profile Riabni
Generic: Rituximab
Class: CD20 / CD38 Targeted Cytolytic Antibody
Indications: Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Direct Communication & Assistance
Send an Inquiry to Oncology Therapeutics / NCI
Our oncology navigation desk will route your inquiry regarding medicine access, clinical partnerships, or product availability to the appropriate representative.
